Tag: Erbitux
Addition of Cetuximab to CRT Cuts Locoregional Failure in Anal CA
Findings in patients with stage I to III squamous cell carcinoma of the anal canal
Cetuximab + Chemoradiation Can Cure HIV-Associated Anal Cancer
Addition of cetuximab may result in less locoregional failure for squamous cell carcinoma of anal canal
Possible Benefit for Addition of Cetuximab to RT in Laryngeal CA
Nonsignificant increase in laryngeal preservation, laryngectomy-free survival with cetuximab plus RT
